Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
MTNB
$3.14
+11.35%
MTNB
· Matinas BioPharma Holdings, Inc.
$3.14
+0.32 (+11.35%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company does not believe that the cash and cash equivalents on hand are sufficient to fund planned operations for a period of at least twelve months from the filing date of these financial statements. As a result, substantial doubt exists about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$2.48M
Shares
979,520
Volume · Oct 5
183.97K
Avg daily vol (6 sessions)
259.9K
All webcasts
Earnings call · FY2019 Q4
Matinas BioPharma Holdings, Inc. (MTNB) Q4 2019 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Net income · derived Q4
-$5.57M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 9, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 9, 2020 · complete as-filed document